These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21837654)

  • 41. Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea.
    Kamiya K; Wang M; Uchida S; Amano S; Oshika T; Sakuragawa N; Hori J
    Exp Eye Res; 2005 May; 80(5):671-9. PubMed ID: 15862174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
    Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
    Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye.
    Ko JH; Lee HJ; Jeong HJ; Kim MK; Wee WR; Yoon SO; Choi H; Prockop DJ; Oh JY
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):158-63. PubMed ID: 26699483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells.
    Wang Y; Wang M; Abarbanell AM; Weil BR; Herrmann JL; Tan J; Novotny NM; Coffey AC; Meldrum DR
    Surgery; 2009 Aug; 146(2):198-205. PubMed ID: 19628074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
    Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
    Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling.
    Pijnappels DA; Schalij MJ; van Tuyn J; Ypey DL; de Vries AA; van der Wall EE; van der Laarse A; Atsma DE
    Cardiovasc Res; 2006 Nov; 72(2):282-91. PubMed ID: 16956599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human bone marrow mesenchymal stem cells expressing SDF-1 promote hematopoietic stem cell function of human mobilised peripheral blood CD34+ cells in vivo and in vitro.
    Liang X; Su YP; Kong PY; Zeng DF; Chen XH; Peng XG; Zou ZM; Xu H
    Int J Radiat Biol; 2010 Mar; 86(3):230-7. PubMed ID: 20201651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling.
    Gur-Wahnon D; Borovsky Z; Beyth S; Liebergall M; Rachmilewitz J
    Exp Hematol; 2007 Mar; 35(3):426-33. PubMed ID: 17309823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced engraftment of mesenchymal stem cells in a cutaneous wound model by culture in allogenic species-specific serum and administration in fibrin constructs.
    Gregory CA; Reyes E; Whitney MJ; Spees JL
    Stem Cells; 2006 Oct; 24(10):2232-43. PubMed ID: 16763199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia.
    Hara Y; Stolk M; Ringe J; Dehne T; Ladhoff J; Kotsch K; Reutzel-Selke A; Reinke P; Volk HD; Seifert M
    Transpl Int; 2011 Nov; 24(11):1112-23. PubMed ID: 21880071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of early systemic betamethasone or cyclosporin A after corneal alkali injury via inflammatory cytokine reduction.
    Den S; Sotozono C; Kinoshita S; Ikeda T
    Acta Ophthalmol Scand; 2004 Apr; 82(2):195-9. PubMed ID: 15043540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal stem cells and their potential as cardiac therapeutics.
    Pittenger MF; Martin BJ
    Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic efficacy of different routes of mesenchymal stem cell administration in corneal injury.
    Shukla S; Mittal SK; Foulsham W; Elbasiony E; Singhania D; Sahu SK; Chauhan SK
    Ocul Surf; 2019 Oct; 17(4):729-736. PubMed ID: 31279065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice.
    Chou SH; Kuo TK; Liu M; Lee OK
    J Orthop Res; 2006 Mar; 24(3):301-12. PubMed ID: 16482576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro.
    Moriscot C; de Fraipont F; Richard MJ; Marchand M; Savatier P; Bosco D; Favrot M; Benhamou PY
    Stem Cells; 2005 Apr; 23(4):594-603. PubMed ID: 15790780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential.
    di Bonzo LV; Ferrero I; Cravanzola C; Mareschi K; Rustichell D; Novo E; Sanavio F; Cannito S; Zamara E; Bertero M; Davit A; Francica S; Novelli F; Colombatto S; Fagioli F; Parola M
    Gut; 2008 Feb; 57(2):223-31. PubMed ID: 17639088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesenchymal Stem Cells Ameliorated Glucolipotoxicity in HUVECs through TSG-6.
    An X; Li L; Chen Y; Luo A; Ni Z; Liu J; Yuan Y; Shi M; Chen B; Long D; Cheng J; Lu Y
    Int J Mol Sci; 2016 Apr; 17(4):483. PubMed ID: 27043548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterisation of rat corneal cells that take up soluble antigen: an in vivo and in vitro study.
    McMenamin PG; Kezic J; Camelo S
    Exp Eye Res; 2006 Nov; 83(5):1268-80. PubMed ID: 16934806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.